Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.

MLA

Nielsen, F. S., et al. “Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbuminuric NIDDM Patients.” Diabetes Care, vol. 21, no. 5, May 1998, pp. 804–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs9058695&authtype=sso&custid=ns315887.

APA

Nielsen, F. S., Sato, A., Ali, S., Tarnow, L., Smidt, U. M., Kastrup, J., & Parving, H. H. (1998). Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care, 21(5), 804–809.

Chicago

Nielsen, F S, A Sato, S Ali, L Tarnow, U M Smidt, J Kastrup, and H H Parving. 1998. “Beneficial Impact of Ramipril on Left Ventricular Hypertrophy in Normotensive Nonalbuminuric NIDDM Patients.” Diabetes Care 21 (5): 804–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs9058695&authtype=sso&custid=ns315887.